AIIMS CRE 2025
Pharmacology
Medium

Which ARV drug is included to prevent mother-to-child transmission during breastfeeding?

Appeared in: AIIMS CRE 2025

Explanation

  • Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used for infant prophylaxis to prevent mother-to-child HIV transmission.
  • It is particularly indicated in regimens for high-risk infants, where the risk of transmission (including through breastfeeding) is elevated.
  • While maternal viral suppression is the primary goal, infant prophylaxis with drugs like Nevirapine provides an essential secondary layer of protection.
  • Global health guidelines (like WHO) have historically recommended daily Nevirapine for the infant throughout the breastfeeding period in resource-limited settings.

Why Other Options Were Wrong

  • Option A: Zidovudine is used as a standard, short-term (2-6 weeks) prophylaxis for all HIV-exposed newborns, not specifically for extended protection during breastfeeding.
  • Option C: Efavirenz is a component of adult and older children's ART regimens but is not recommended for neonatal prophylaxis due to potential CNS side effects and lack of dosing data for newborns.
  • Option D: Stavudine is an older drug that is no longer recommended for use due to its high rate of severe and irreversible side effects, such as lipoatrophy and peripheral neuropathy.

Related Visual

Chart comparing different ARV prophylaxis regimens for neonates low-risk vs. high-risk, highlighting the inclusion of Nevirapine in high-risk protocols.
Clinical Relevance
  • Nursing practice connection: Use the key finding related to Antiretroviral (ARV) prophylaxis for Prevention of Mother-to-Child Transmission (PMTCT) to guide bedside assessment, documentation, and the next nursing action.
  • Nurses play a crucial role in PMTCT by providing non-judgmental, evidence-based counseling to mothers about ART adherence, infant feeding choices, and the importance of infant prophylaxis.
  • Patient education is key. The nurse must ensure the parent can correctly administer the medication to the infant and understands the follow-up schedule for both themselves and the baby.
  • What if the mother's viral load is unknown or detectable (>1,000 copies/mL) at delivery? The infant is considered high-risk. This mandates immediate initiation of a multi-drug presumptive HIV therapy regimen, which often includes Zidovudine, Lamivudine, and Nevirapine, instead of just Zidovudine monotherapy.
How to Approach the Question
  • First, identify the key concepts in the question: 'ARV drug', 'mother-to-child transmission', and 'breastfeeding'. This points to infant prophylaxis.
  • Differentiate between antiretroviral therapy for the mother and prophylaxis for the infant. The question is about the infant.
  • Recall the standard drugs used for infant prophylaxis. Zidovudine and Nevirapine are common, while Efavirenz and Stavudine are not used for this purpose.
  • Differentiate the roles of Zidovudine and Nevirapine. Zidovudine is the standard short-term prophylaxis for all. Nevirapine is often added or used in specific high-risk scenarios or for extended prophylaxis related to breastfeeding.
  • Eliminate Stavudine as it is an outdated drug with severe toxicity. Eliminate Efavirenz as it is not used in neonates. Between Zidovudine and Nevirapine, Nevirapine is the drug specifically associated with breastfeeding prophylaxis in many guidelines.
Concept Tested & Keywords
  • Concept Tested: Antiretroviral (ARV) prophylaxis for Prevention of Mother-to-Child Transmission (PMTCT)
  • Stem keywords: ARV drug, prevent mother-to-child transmission, breastfeeding
  • Lead-in keywords: Which
  • Clinical cues: Age/sex group narrows the expected diagnosis, intervention, or normal reference range.
  • Negative lead-in flag: false

Question ID

Q0B0bevcdhEG0O2dAhzA6Y

Reference Book

E6 Nelson Textbook of Pediatrics(2024) — Volume 1 pp. 2120-2122, 2106-2108

E6 Pharmacology Katzung 16e p. 1357-1359

Practise the full AIIMS CRE 2025

Attempt every question from this paper in a timed mock, then review the full solution for each one.

More Antimicrobial Drugs Questions

More AIIMS CRE 2025 Questions